EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alpha-synuclein overexpression does not cause vocalization deficits in a mouse model of parkinsonism

Brooke Rodgers, Allison Schaser iD

Biology Open · 2025

DOI: 10.1242/bio.062120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology Open, 2025. Verfasst von Brooke Rodgers und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Speech, Language, and Hearing Sciences, Purdue University, West Lafayette, IN 47907, USA. Hauptthemen laut MEDLINE: alpha-Synuclein, Vocalization, Animal, Gene Expression, Parkinsonian Disorders. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Collins Medical Trust, American Speech-Language-Hearing Association, American Speech-Language Hearing Foundation New Investigators Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Voice deficits are common in Parkinson's disease (PD) and significantly impact quality of life by increasing stress, social isolation, and caregiver burden. However, despite this impact, there are currently no treatments that target the underlying pathophysiology of PD in the vocalization system. The goal of this study was to examine the effect of one possible underlying mechanism responsible for the complex voice deficits that exist in PD; overexpression of the protein alpha-synuclein. Results show that overexpression of alpha-synuclein, prior to the development of alpha-synuclein aggregate pathology, does not result in significant vocalization deficits. A small but statistically significant increase in the total number of complex vocalizations was found in mice overexpressing alpha-synuclein compared to wild-type mice, but there were no differences in complexity ratio or any of the other specific vocalization parameters tested. Results provide a critical foundational understanding of the impact of overexpression versus aggregation of alpha-synuclein on voice deficits in PD. Future work will focus on manipulation of alpha-synuclein aggregate pathology, and not overexpression alone, to reduce or eliminate the burden of PD specific voice disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinVocalization, AnimalGene ExpressionParkinsonian DisordersAnimalsDisease Models, AnimalMiceMaleParkinson DiseaseMice, Transgenic

Stichwörter der Autor:innen

Alpha-synucleinMouse modelParkinsonismUltrasonic vocalizationsVoice

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Department of Speech, Language, and Hearing Sciences, Purdue University, West Lafayette, IN 47907, USA.

ORCID-Profile: Allison Schaser

Förderung

  • Collins Medical Trust
  • American Speech-Language-Hearing Association
  • American Speech-Language Hearing Foundation New Investigators Research Grant
  • Purdue University

Zitieren

APA

Rodgers, B., & Schaser, A. (2025). Alpha-synuclein overexpression does not cause vocalization deficits in a mouse model of parkinsonism. Biology Open. https://doi.org/10.1242/bio.062120

Vancouver

Rodgers B, Schaser A. Alpha-synuclein overexpression does not cause vocalization deficits in a mouse model of parkinsonism. Biology Open. 2025. doi:10.1242/bio.062120

BibTeX
@article{Rodgers2025,
  author = {Rodgers, Brooke and Schaser, Allison},
  title = {Alpha-synuclein overexpression does not cause vocalization deficits in a mouse model of parkinsonism},
  journal = {Biology Open},
  year = {2025},
  doi = {10.1242/bio.062120}
}
Kostenlos starten →